Riskpilot← Back to searchSign inGet full accessAbasin Med AB
ABActiveOrg 5593028128Löftesgatan 1General medical practice activities · NACE 8621Est. 20211 employees
Revenue 2025
SEK 332K
-46% vs 2024
EBITDA margin
62.4%
-41% vs 2024
Equity ratio
76.6%
Financial strength
Net profit 2025
SEK 166K
-29% vs 2024
| Revenue | SEK 332K | -46% |
| EBITDA | SEK 207K | -41% |
| Net profit | SEK 166K | -29% |
| Total assets | SEK 1M | +23% |
| Equity | SEK 792K | -6% |
| Employees | 1 | — |
Legal name
Abasin Med AB
Org number
5593028128
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
18 februari 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva uthyrning av personal inom medicinsk vård, allmänmedicin och slutenvård.
Address
Löftesgatan 1
Email
habibrsafi@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 418 | 966 | 316 | 617 | 332 |
| Staff expenses | — | −266 | −17 | −90 | −128 |
| EBITDA | 894 | 564 | 189 | 352 | 207 |
| Depreciation & amort. | −58 | −58 | −58 | −58 | — |
| EBIT | 836 | 506 | 131 | 293 | 207 |
| Net financials | −1 | 0 | −3 | 3 | 2 |
| Profit before tax | 835 | 506 | 128 | 297 | 209 |
| Tax | −173 | −105 | −26 | −63 | −43 |
| Net profit | 662 | 401 | 102 | 233 | 166 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 963 | 1 129 | 803 | 844 | 1 034 |
| Equity | 687 | 901 | 815 | 844 | 792 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 275 | 228 | −12 | −0 | 242 |
| Total debt | 275 | 228 | −12 | −0 | 242 |
EBITDA margin
62.4%
This company
15.8%
Market median
+295% vs market
20212025
Equity ratio
76.6%
This company
38.2%
Market median
+101% vs market
20212025
Return on equity
21.0%
This company
18.4%
Market median
+14% vs market
20212025
Net profit margin
50.0%
This company
8.1%
Market median
+517% vs market
20212025
Asset turnover
0.32×
This company
1.12×
Market median
-71% vs market
20212025
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-02-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Former (4) | ||
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Abasin Med AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Habib Abasin Safi | Board of Directors | 0 companies |
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Khushbo Safi | Deputy Board Member | 0 companies |
| Khushbo Safi | Deputy Board Member | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |